SCHEMBL24323734

SCHEMBL24323734

COC(=O)c1cncc(N2CCCC[C@H]2C)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.40
MAPT P10636 4/20 0.38
PRMT5 O14744 1/20 0.38
WDR77 Q9BQA1 1/20 0.38
KDM4E B2RXH2 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
CDK5 Q00535 1/20 0.37
DYRK1A Q13627 1/20 0.37
CDK5R1 Q15078 1/20 0.37
CD38 P28907 1/20 0.37
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
CHRM4 P08173 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
GAA P10253 2/20 0.36
SYK P43405 2/20 0.36
ATM Q13315 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24324614 0.96 ADORA2A (0.39) ALDH1A1KDM4ECD38ADORA2AADORA1
SCHEMBL29600599 0.96 ADORA2A (0.39) ALDH1A1KDM4ECD38ADORA2AADORA1
SCHEMBL31014743 0.79 NPC1 (0.40) KDM4EMEN1KMT2ACD38SMN1; SMN2
SCHEMBL24323742 0.78 NPC1 (0.41) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL21044370 0.77 ALDH1A1 (0.42) ALDH1A1MAPTKDM4EL3MBTL1MEN1
SCHEMBL24270196 0.76 ADORA2A (0.43) ALDH1A1MAPTKDM4EL3MBTL1ADORA2A
SCHEMBL24270195 0.76 ADORA2A (0.43) ALDH1A1MAPTKDM4EL3MBTL1ADORA2A
SCHEMBL20031580 0.74 RBP4 (0.40) CD38
SCHEMBL1326312 0.74 ALDH1A1 (0.44) ALDH1A1MAPTKDM4EL3MBTL1MEN1
SCHEMBL24324092 0.73 MAPT (0.41) ALDH1A1MAPTKDM4EL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076622-A2 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed